Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading AlloVir Inc chart...

About the Company

allovir, inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific t cell (vst) therapies to prevent and treat devastating viral-associated diseases. the company's lead product is viralym-m, an allogeneic, off-the-shelf vst therapy, to treat bk virus, cytomegalovirus, adenovirus, epstein-barr virus, and human herpesvirus 6. its preclinical and clinical development product candidates include alvr106 for respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; alvr109 to treat sars-cov-2 and covid-19; alvr107 for treating hepatitis b; and alvr108 to treat human herpesvirus-8, including kaposi's sarcoma, primary effusion lymphoma, and multicentric castleman's diseases. the company was formerly known as viracyte, inc. and changed its name to allovir, inc. in may 2019. allovir, inc. was founded in 2013 and is based in cambridge, massachusetts.

CEO

Scott M. McFarlane

Exchange

NASDAQ

Website

allovir.com

$0M

Total Revenue

131

Employees

$87M

Market Capitalization

-0.43

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ALVR News

ALVR DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadli…

10d ago, source: Business Wire

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) ...

Levi & Korsinsky Notifies Shareholders of AlloVir, Inc. (ALVR) of a Class Action Lawsuit and an Upcoming Deadline

16d ago, source: Stockhouse

THE LAWSUIT: A class action securities lawsuit was filed against AlloVir, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between March 22, ...

AlloVir, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALVR

15d ago, source: Business Insider

NEW YORK, NY / ACCESSWIRE / March 13, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, ...

Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

17d ago, source: Business Insider

NEW YORK, NY / ACCESSWIRE / March 11, 2024 / If you suffered a loss on your AlloVir, Inc. (NASDAQ:ALVR) investment and want to learn about a potential recovery under the federal securities laws, ...

Reddit rockets as investors receive latest AI IPO

on MSN ago, source:

Reddit (RDDT) shares soared in their debut on the public markets, gaining 38% on Thursday, as initial public offerings ...

Stocks Fluctuate Before Feb ISM Manufacturing Report

26d ago, source: The Globe and Mail

ACELYRIN Inc (SLRN), Allovir Inc (ALVR), Amneal Pharmaceuticals Inc (AMRX), AnaptysBio Inc (ANAB), Cardlytics Inc (CDLX), Cartesian Therapeutics Inc (RNAC), ClearPoint Neuro Inc (CLPT), Desktop Metal ...

ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

20d ago, source: Stockhouse

THE LAWSUIT: A class action securities lawsuit was filed against AlloVir, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between March 22, ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...